WHO ICTRP trial

A clinical trial to understand the effect of Vitamin C, Thiamine and…

CTRI/2018/07/014787 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2018/07/014787
Public title A clinical trial to understand the effect of Vitamin C, Thiamine and hydrocortisone combination in patients with severe infections
Scientific title A prospective, open label, randomized controlled trial to evaluate the effect of intravenous vitamin C, Thiamine and Hydrocortisone treatment on all cause mortality among patients with severe sepsis and septic shock. - ViCTOR
Primary sponsor Amrita Institute of Medical Sciences
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type Interventional
Phase Phase 3/ Phase 4
Countries India
Conditions Health Condition 1: null- Adult patients admitted to ICU with primary diagnosis of sepsis/septic shock
Interventions Intervention1: Vitamin C, Thiamine and Hydrocortisone: For intervention arm, administration of intravenous vitamin C (1.5 gm Q6H) for 4 days, hydrocortisone (50 mg Q6H followed by tapering) for atleast 4 days, as well as intravenous…
Registration date Oct 7, 2018
Target size 84
Secondary IDs NIL
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations